News Stories Research

Andriole Receives Richard D. Williams, MD Prostate Cancer Research Excellence Award

Gerald L. Andriole, MD, Robert K. Royce Distinguished Professor and Chief of the Division Urologic Surgery at Washington University School of Medicine, has received the 2021 Richard D. Williams, MD, Prostate Cancer Research Excellence Award.

Since its creation in 2013, the Urology Care Association of the American Urologic Association has annually presented the Williams Award, named in honor of the late urologist, scientist, mentor and humanitarian, for outstanding and impactful research and work in the field of prostate cancer.

“It is truly an honor to receive this award and recognition,” says Andriole. “The field of prostate cancer research has made great strides over the years, and Washington University urologists have been at the forefront of these advances. From the development of PSA testing, pioneering minimally invasive surgical approaches, and novel imaging of prostate cancer the Division of Urologic Surgery has a long and distinguished tradition of innovation and excellence in prostate cancer research and patient care.”

Andriole combines excellence in research and patient care. His career has focused on prostate cancer prevention, new approaches to prostate cancer detection and imaging of prostate cancer. An innovator in the field, he established an image guided prostate biopsy approach that utilizes MRI and microultrasound techniques. Andriole and a team of Washington University urologists and researchers are currrently investigating other potential cancer screening tests, including blood and urine tests that measure cancer-related biomarkers.

“Dr. Andriole’s expertise on prostate cancer has led to innovations in screening and clinical care that have improved the lives of countless patients,” says Timothy Eberlein, MD, the William K. Bixby Professor and Chair of the Department of Surgery and Director of Siteman Cancer Center.

Washington University Urology and Siteman Cancer Center offer multidisciplinary, targeted treatment approach when patients are faced with life-altering prostate cancer diagnoses. Washington University Urology also provides advanced medical treatment for conditions such as kidney stone disease, urinary incontinence, male infertility and sexual dysfunction as well as bladder, kidney and testicular cancer. 

Siteman Cancer Center has been recognized as a top cancer institution by the National Cancer Institute, part of the National Institutes of Health, and is the St. Louis region’s only NCI-designated Comprehensive Care Center.

In the past, this award was presented at the Urology Care Foundation Research Honors Program and Reception held during the American Urological Association’s Annual Meeting. Due to the COVID-19 pandemic, the conference was held virtually.